LONDON, UK: Sproutly Canada and Apollon Formularies have announced the completion of their due diligence. Sproutly, a Canadian company that specializes in natural cannabinoids, terpenes, and mushroom compounds, is poised to acquire all global assets of Apollon, a UK-based company that focuses on natural biologics drug discovery, integrating cutting-edge artificial intelligence (AI) technology. The transaction,…